124-03-8
CAS 124-03-8
124-03-8 (CAS 124-03-8) is a pharmaceutical compound with 4 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 22672.63448275862 nM | 28 | - |
| - | IC50 | 14551.805 nM | 24 | - |
| - | AC50 | 13450.679999999998 nM | 10 | - |
| - | EC50 | 9213.888888888889 nM | 9 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| Mecetronium Bromide | 1427238 | SU | MTHSPL |
| Mecetronium bromide | 1427238 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is 124-03-8 used for in pharmaceutical contexts?
124-03-8 (CAS 124-03-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for 124-03-8?
No adverse-event association or SIDER side-effect rows are rendered for 124-03-8 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is 124-03-8 also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Cetethyldimonium Bromide with EU status "permitted".
What clinical phase is 124-03-8 in?
No phase 1-4 clinical development badge is rendered for 124-03-8 because the matched compound identifier rows do not contain a max-phase value.